Answers are grounded in this paper and cite their sources.
Systematic review assesses osteosarcoma in jaws using histomorphology and immunohistochemistry, highlighting diagnostic importance.
Background: Osteosarcomas are highly malignant bone tumours characterised by the presence of malignant mesenchymal cells producing osteoid or immature bone. Osteosarcoma of the jaws (OSJ) is making up 6% to 9% of all cases of OS and 1% of all head and neck malignancies with mandibular predilection. OSJ tend to occur in third to fourth decade of life with slight male predilection. Although the exact cause of OS is still unknown, A strong association with the adolescent growth spurt and hormonal factors may play a role. Additional risk factors include radiation exposure, alkylating agents, chronic osteomyelitis, trauma, viral infection, metallic implants, fibrous dysplasia, Paget disease of bone. Defects in RB, p53 and chromosome 21q, INK4a, DNA helicase genes play an important role in the process. The diagnosis involves clinico-radiological and histological correlation. The aim of this study {Systematic review and case series} to see various forms of osteosarcoma affecting jaw bone with histomorphology and immunohistochemistry. Method: Total 6 cases were included in this study visited to GDC and H, Ahmedabad and case series with a systematic review was performed. Pubmed, Cochrane and Google Scholar were used as search engine. The literature research was done by using clearly defined terms and their links. Total 26 article selected and evaluated for this review. Conclusion: Osteosarcoma is an uncommon condition with unusual presentation and various histopathological patterns. The process of diagnosing Osteosarcoma was based on an integrated study of clinical, radiologic, histopathologic and immunohistochemistry findings. Though histological examination is gold standard, Immunohistochemical analysis plays an important role in establishing the histogenetic origin of many entities thus helps in accurate diagnosis and prompt treatment. So, clinician should have thorough knowledge of relationship between IHC and bone tumors.
No takes yet. Share an insight, caveat, or question.
Buktare et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: